GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy
Alzheimer’s disease (AD) is the most common form of dementia present in older adults; its etiology involves genetic and environmental factors. In recent years, epidemiological studies have shown a correlation between AD and chronic epilepsy since a considerable number of patients with AD may present...
Main Authors: | Danira Toral-Rios, Pavel S. Pichardo-Rojas, Mario Alonso-Vanegas, Victoria Campos-Peña |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fncel.2020.00019/full |
Similar Items
-
GSK-3 and Tau: A Key Duet in Alzheimer’s Disease
by: Carmen Laura Sayas, et al.
Published: (2021-03-01) -
GSK-3β, a pivotal kinase in Alzheimer disease
by: Maria eLLorens-Martin, et al.
Published: (2014-05-01) -
Overexpression of GSK-3β in Adult Tet-OFF GSK-3β Transgenic Mice, and Not During Embryonic or Postnatal Development, Induces Tau Phosphorylation, Neurodegeneration and Learning Deficits
by: Alberto Rodríguez-Matellán, et al.
Published: (2020-09-01) -
Modulation of GSK-3 as a therapeutic strategy on Tau pathologies
by: Miguel eMedina, et al.
Published: (2011-10-01) -
Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301L × GSK3β mice by delaying brainstem tauopathy
by: Natalia Crespo-Biel, et al.
Published: (2014-07-01)